Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYDRATE: Oral vs IV Hydration for CIN Prevention
NCT01093131Phase 4Withdrawn
- Sponsor
- West Penn Hospital
- Start
- Feb 2005
- Primary completion
- Sep 2009
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium bicarbonate ringer's solution in contrast-induced nephropathy (CIN) (4 arms), sponsored by West Penn Hospital. Primary endpoint: Contrast Induced Nephropathy at 72 hours. Planned start Feb 2005; status: withdrawn.
02
Drugs
sodium bicarbonate ringer's solution
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT01093131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01093131.